0.75 CME Credits. This webinar discusses ADHD and its varied presentations, co-occurring issues, and the importance of accurate assessment for effective treatment.

0.50 CME Credits. Dr. Collier explores diagnosis, overlapping symptoms, and treatments for delirium in older adults.

0.25 CME Credits. In this episode, we explore nine groundbreaking stories in mental health and psychiatric medicine, covering everything from healthcare fraud to the latest advancements in drug trials. First, we dive into the recent charges brought by the US Department of Justice against executives at Done, a California-based telehealth company, for alleged healthcare fraud. Done is accused of prescribing over 40 million Adderall pills to patients without proper evaluation, raising concerns about the balance between increasing mental healthcare access and responsible prescribing practices.

0.25 CME Credits. Highlights from this month include Lumateperone, Lavender, treatment resistant smoking, and Clonidine patches and Tourettes. A new meta analysis published in Psychiatry Research sheds light on a critical question.

0.50 CME Credits. Learn how to address depression in older adults, identify the risk factors and triggers, distinguish depression from normal aging, and explore effective treatment options.

Meds that require special skill to start: Clozapine and lamotrigine.

A teen is using substances—how do you decide what kind of treatment makes sense? Outpatient therapy? A more structured program? We’re breaking it down.

Ziprasidone and quetiapine. One goes better fast, one slow. Also the mystery of ghost pills, and a research update on pramipexole.

The FDA just approved the cyclobenzaprine (Tonmya, Flexeril) for fibromyalgia. We look at three risks that medication raises in psychiatry.

The FDA just approved Ketarx for surgical pain, but the company has its eyes on depression.

We’re often told antipsychotics are a last resort for agitation in dementia. And that’s true—they are. But when you do reach that last resort, you need to know how to use it—and how to talk about it with families.

We ask about alcohol.

We ask about weed.

Sometimes we even ask about TikTok.

But porn?

What happens when the patient doesn’t want therapy?

How do you approach patients who ask about cannabis for anxiety?

A reminder that focus problems don’t always mean ADHD. That suffering doesn’t always need a label. And that quick relief can sometimes do lasting harm.